Clinical Trial Update: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine [Phase 2]

View source ↗

Summary

Phase 2 trial investigating oral treprostinil diethanolamine for digital ischemic lesions in systemic sclerosis (scleroderma) completed with posted results in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Drugs mentioned

• Treprostinil diethanolamine (treprostinil diethanolamine)

Snippet

Sponsor: United Therapeutics | Conditions: Systemic Sclerosis, Scleroderma | Phase 2 | Status: COMPLETED | Results posted: 2014-03-17